Madrid’s reduction of its debt to the leading private healthcare network Quirónsalud has been one of the most significant changes in the regional healthcare system in recent years. For local residents, this means not only a shift in financial priorities, but also potential changes in access to medical services. Questions about transparency and the impact of such decisions remain relevant across Spain.
According to El Pais, by the end of 2025 the Madrid government’s debt to four Quirónsalud hospitals stood at 427 million euros. This is the lowest level since 2017 and nearly half the 2019 figure, when the debt reached 1.004 billion. Over seven years, the region paid off 577 million euros, the result of accelerated repayment of old obligations alongside the accumulation of new debt.
Quirónsalud operates 57 hospitals in Spain and Latin America, four of which serve Madrid residents: Fundación Jiménez Díaz, as well as hospitals in Móstoles, Villalba, and Valdemoro. The first is directly owned by Quirónsalud, while the others operate under a concession model in which the government transfers management to a private company. This funding arrangement has sparked debate among experts and politicians.
Financial decisions and payments
At the end of 2025, Madrid authorities approved payments to Quirónsalud totaling nearly 500 million euros. These funds were allocated to cover the population’s healthcare expenses. In early 2026, additional payments amounting to 17.7 million euros were approved, part of which relates to court rulings on old debts and VAT refunds for previous years.
According to a report by Fresenius, which owns Quirónsalud, Madrid’s debt accounts for 12% of the company’s total overdue liabilities. Over the years, the region’s debt has fluctuated: in 2020 it reached a record 1.248 billion euros, after which it began to decline. This trend is attributed both to more frequent payments and a continued rise in new obligations due to expanding services.
Quirónsalud management notes that the company’s financial performance improved in 2025, supported by active debt management and strong demand for medical services. However, details of the agreements between the government and the private operator remain undisclosed to the wider public, fueling distrust in the system.
Controversy over the cooperation
Collaboration between Madrid and Quirónsalud has been accompanied by several conflicts. Firstly, it serves as a prominent example of large-scale public-private partnerships in healthcare, prompting debates over whether this model is appropriate. Secondly, the significant sums transferred to Quirónsalud have become a topic of public discussion, especially amid investigations involving companies linked to individuals close to regional authorities.
In addition, the settlement system between the government and the private operator often becomes the subject of legal disputes. Some debts that are currently being paid off were accrued under previous administrations, highlighting the complexity and length of financial relations in this sector.
As El Pais notes, the annual audit of Fresenius records all overdue and disputed debts, allowing shareholders to track the dynamics of payments. However, for local residents, it remains unclear how funds are distributed and what impact this has on the quality of medical services.
Long-term consequences
A reduction in debt does not mean the problem is fully resolved: the system continues to generate new liabilities, and repayments on old debts can drag on for years. In the near future, cooperation is expected to expand, for example, by transferring laboratory management to a private operator, which may lead to new financial obligations.
Transparency and the effective use of public funds remain in the spotlight. For many Madrid residents, it is important to understand how such decisions affect the accessibility and quality of healthcare. Analysis by russpain.com indicates that these situations are typical not only for Madrid but also for other regions of Spain, where the state actively cooperates with private companies in the healthcare sector.
In recent years, Spain has repeatedly faced heated debates over the funding of private healthcare providers with public money. In Valencia and Catalonia, there have also been cases of transferring the management of public hospitals to private companies, sparking protests and legal proceedings. In some regions, such arrangements have led to temporary suspension of payments or a review of contract terms. These developments highlight that issues of transparency and oversight in healthcare spending remain relevant throughout the country.
